Evaluation of salicylic acid fatty ester prodrugs for UV protection

References

• Trommer H, Neubert RH. (2006). Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol, 19:106–121.
   PubMed Web of Science ®Google Scholar
• Asbill CS, Michniak BB. (2000). Percutaneous penetration enhancers: local versus transdermal activity. Pharm Sci Technol Today, 3:36–41.
   PubMedGoogle Scholar
• Hadgraft J. (1996). Recent developments in topical and transdermal delivery. Eur J Drug Metab Pharmacokinet, 21:165–173.
   PubMed Web of Science ®Google Scholar
• Andega S, Kanikkannan N, Singh M. (2001). Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release, 77:17–25.
   PubMed Web of Science ®Google Scholar
• Aungst B, Rogers N, Shefter E. (1986). Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm, 33:225–234.
   Web of Science ®Google Scholar
• Cooper ER, Merritt EW, Smith RL. (1985). Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J Pharm Sci, 74:688–689.
   PubMed Web of Science ®Google Scholar
• Kanikkannan N, Kandimalla K, Lamba SS, Singh M. (2000). Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem, 7:593–608.
   PubMed Web of Science ®Google Scholar
• Kanikkannan N, Singh M. (2002). Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm, 248:219–228.
   PubMed Web of Science ®Google Scholar
• Lee CK, Uchida T, Noguchi E, Kim NS, Goto S. (1993). Skin permeation enhancement of tegafur by ethanol/panasate 800 or ethanol/water binary vehicle and combined effect of fatty acids and fatty alcohols. J Pharm Sci, 82:1155–1159.
   PubMed Web of Science ®Google Scholar
• Goodman M, Barry B. (1989). Lipid-protein-partitioning: LPP; theory of skin enhancer activity: finite dose technique. Int J Pharm, 57:29–40.
   Web of Science ®Google Scholar
• Williams AC, Barry BW. (1992). Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst, 9:305–353.
   PubMed Web of Science ®Google Scholar
• Bhandari KH, Newa M, Yoon SI, Kim JS, Jang KY, Kim JA et al. (2007). Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs. Biol Pharm Bull, 30:2211–2216.
   PubMed Web of Science ®Google Scholar
• Doh HJ, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH et al. (2003). Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery. J Pharm Sci, 92:1008–1017.
   PubMed Web of Science ®Google Scholar
• Kim BY, Doh HJ, Le TN, Cho WJ, Yong CS, Choi HG et al. (2005). Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies. Int J Pharm, 293:193–202.
   PubMed Web of Science ®Google Scholar
• Setoh K, Murakami M, Araki N, Fujita T, Yamamoto A, Muranishi S. (1995). Improvement of transdermal delivery of tetragastrin by lipophilic modification with fatty acids. J Pharm Pharmacol, 47:808–811.
   PubMed Web of Science ®Google Scholar
• Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM. (1990). Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest, 86:1738–1745.
   PubMed Web of Science ®Google Scholar
• Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM. (1993). Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest, 91:1656–1664.
   PubMed Web of Science ®Google Scholar
• Mao-Qiang M, Elias PM, Feingold KR. (1993). Fatty acids are required for epidermal permeability barrier function. J Clin Invest, 92:791–798.
   PubMed Web of Science ®Google Scholar
• Man MQ, Feingold KR, Elias PM. (1993). Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol, 129:728–738.
   PubMed Web of Science ®Google Scholar
• Shah H, Tojo K, Chien Y. (1992). Transdermal controlled delivery of verapamil: characterization of in vitro skin permeation. Int J Pharm, 86:167–173.
   Web of Science ®Google Scholar
• Sarveiya V, Risk S, Benson HA. (2004). Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers. J Chromatogr B Analyt Technol Biomed Life Sci, 803:225–231.
   PubMed Web of Science ®Google Scholar
• Benfeldt E. (1999). In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects. Acta Derm Venereol Suppl (Stockh), 206:1–59.
   PubMedGoogle Scholar
• Singh P, Roberts MS. (1994). Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther, 268:144–151.
   PubMed Web of Science ®Google Scholar
• Wurster DE, Kramer SF. (1961). Investigation of some factors influencing percutaneous absorption. J Pharm Sci, 50:288–293.
   PubMed Web of Science ®Google Scholar
• Yano T, Nakagawa A, Tsuji M, Noda K. (1986). Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sci, 39:1043–1050.
   PubMed Web of Science ®Google Scholar
• Society of Toxicology (SOT) (2008). Guiding Principles in the Use of Animals in Toxicology. http://www.toxicology.org/AI/FA/guidingprinciples.pdf.
   Google Scholar
• Kuo P, Liu J, Chang S, Chien Y. (1989). In vitro transdermal permeation of oxycodone: (I) effect of pH, delipidization and skin stripping. Drug Dev Ind Pharm, 15:1199–1215.
   Web of Science ®Google Scholar
• Michniak B, Player M, Chapman J, Sowell J. (1994). Azone analogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention. J Control Release, 32:1471–1474.
   Web of Science ®Google Scholar
• Simonsen L, Petersen MB, Groth L. (2002). In vivo skin penetration of salicylic compounds in hairless rats. Eur J Pharm Sci, 17:95–104.
   PubMed Web of Science ®Google Scholar
• Gwak HS, Chun IK. (2002). Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int J Pharm, 236:57–64.
   PubMed Web of Science ®Google Scholar
• Tsai JC, Guy RH, Thornfeldt CR, Gao WN, Feingold KR, Elias PM. (1996). Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J Pharm Sci, 85:643–648.
   PubMed Web of Science ®Google Scholar
• Walters KA, Brain KR, Howes D, James VJ, Kraus AL, Teetsel NM et al. (1997). Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro. Food Chem Toxicol, 35:1219–1225.
   PubMed Web of Science ®Google Scholar
• Benson HA. (2000). Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol, 1:217–224.
   PubMedGoogle Scholar